Crescent IgA Nephropathy and its association with anti-neutrophil cytoplasm antibody: what do we know?
作者信息
Zamoner Welder, Reis Pâmela Falbo Dos, Silva Vanessa Dos Santos
机构信息
Universidade Estadual Paulista "Júlio de Mesquita Filho", Faculdade de Medicina de Botucatu, Botucatu, SP, Brasil.
出版信息
J Bras Nefrol. 2022 Jan-Mar;44(1):1-2. doi: 10.1590/2175-8239-JBN-2022-E001. Epub 2022 Feb 23.
Abstract
摘要
相似文献
1
Crescent IgA Nephropathy and its association with anti-neutrophil cytoplasm antibody: what do we know?
J Bras Nefrol. 2022 Jan-Mar;44(1):1-2. doi: 10.1590/2175-8239-JBN-2022-E001. Epub 2022 Feb 23.
2
Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura.
Nephrol Dial Transplant. 1992;7(6):534-8.
3
IgA nephropathy associated with liver cirrhosis presenting antineutrophil cytoplasm antibody of IgA class.
Nephron. 1994;68(3):403-4. doi: 10.1159/000188419.
4
IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant?
Am J Kidney Dis. 1998 Feb;31(2):341-4. doi: 10.1053/ajkd.1998.v31.pm9469508.
5
Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation.
Am J Kidney Dis. 1997 Jan;29(1):125-31. doi: 10.1016/s0272-6386(97)90019-6.
6
Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.
Korean J Intern Med. 2016 Jan;31(1):194-6. doi: 10.3904/kjim.2016.31.1.194. Epub 2015 Dec 28.
7
Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy.
Clin Immunol Immunopathol. 1994 Oct;73(1):19-26. doi: 10.1006/clin.1994.1165.
8
An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
BMC Nephrol. 2020 Jul 23;21(1):295. doi: 10.1186/s12882-020-01964-w.
9
IgA class anti-neutrophil cytoplasmic antibodies (IgA-ANCA) in primary IgA nephropathy.
APMIS Suppl. 1989;6:25-6.
10
Treatment of rapidly progressive IgA nephropathy.
Contrib Nephrol. 1995;111:177-82; discussion 182-3. doi: 10.1159/000423894.
本文引用的文献
1
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
2
Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study.
Rheumatol Int. 2019 Nov;39(11):1927-1936. doi: 10.1007/s00296-019-04397-3. Epub 2019 Aug 1.
3
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600.
4
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.
Nat Rev Rheumatol. 2019 Feb;15(2):91-101. doi: 10.1038/s41584-018-0145-y.
5
Recent advances in the physiopathology of IgA nephropathy.
Nephrol Ther. 2018 Apr;14 Suppl 1:S1-S8. doi: 10.1016/j.nephro.2018.02.004.
6
Clinical value of systemic symptoms in IgA nephropathy with ANCA positivity.
Clin Rheumatol. 2018 Jul;37(7):1953-1961. doi: 10.1007/s10067-017-3931-z. Epub 2017 Dec 4.
7
Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study.
Clin Kidney J. 2015 Oct;8(5):482-8. doi: 10.1093/ckj/sfv078. Epub 2015 Aug 30.
8
Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.
Am J Kidney Dis. 2010 Feb;55(2):259-68. doi: 10.1053/j.ajkd.2009.09.031. Epub 2009 Dec 30.
Zotero 插件